Europe
Genmab Announces Phase 3 Study Evaluating Epcoritamab in Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma - Book Publishing Industry Today - EIN Presswire <div class="eh-ribbon"> Trusted News Since…
Europe
… analysis of the first in human HMPL-689 Phase I dose … Europe, with patient enrollment underway. Chi-Med currently retain all rights to … 7340 (Mobile) bmiles@troutgroup.com Europe – Ben Atwell…
Europe
International Community welcomes Parliamentary elections in Qatar - Book Publishing Industry Today - EIN Presswire <div class="eh-ribbon"> Trusted News Since 1995 <span class="prof not-if-mobile-w820">A service for publishing professionals</span> <span class="not-if-mobile-w820">·</span>…
America
CRISPR/Cas9 Gene-Editing Therapy CTX001™ for Severe Hemoglobinopathies Accepted for Plenary Presentation at the 62nd American Society of Hematology (ASH) Meeting and Exposition - Book Publishing Industry Today - EIN Presswire…
Europe
Ahold Delhaize reports strong Q3 results; announces initiatives to solidify position as industry- leading local omnichannel retailer in 2021 and beyond - Book Publishing Industry Today - EIN Presswire <div…
Europe
Oxford Road Fortifies Executive Team - Appoints Steven Abraham as President, Brings on Kraig Kitchin and Jennifer Laine
Christianity
Religious liberty endangered by French Draft Law Against “Separatism”
Europe
UN75: UNYA, NEKOTECH PETITION PRESIDENT AKUFO-ADDO TO INITIATE ECOWAS-MIDDLE EAST MULTILATERAL LABOUR MIGRATION DIALOGUE
Christianity
Macron gets a request from NGOs around the world to have his anti-separatism bill reviewed by Venice Commission
Europe
European Patent Office rules in favor of Sanofi and Regeneron concerning Praluent® (alirocumab)
